Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - OPERATING INCOME
Operating Income VRDN - Viridian Therapeutics, Inc.
-254 M
LAST VALUE
-78.65%
2 YEAR CAGR
-50.38%
5 YEAR CAGR
-104.78%
10 YEAR CAGR